Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68788-8312

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68788-8312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B6d50141 4598 4f04 B407 08df00bf4537 01)

Chemical structure of metoprolol succinate, showing the molecular formula and arrangement of atoms for the active ingredient in METOPROLOL SUCCINATE extended release tablets.*

FDA Label Image

Merit Hf (B6d50141 4598 4f04 B407 08df00bf4537 02)

A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The plot compares metoprolol succinate extended-release tablets to placebo across various subgroups such as geographic region, NYHA class, ejection fraction, etiology, sex, race, previous myocardial infarction, diabetes status, hypertension, and heart rate.*

FDA Label Image

50mg (B6d50141 4598 4f04 B407 08df00bf4537 03)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 50 mg strength. The label indicates the product contains 100 tablets and is manufactured by Cipla Ltd., labeled for Cipla USA, Inc. It includes storage instructions and warnings, printed with NDC 69097-407-07, and features a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.